Enlitisa (shanghai) Pharmaceutical Co., Ltd.
Clinical trials sponsored by Enlitisa (shanghai) Pharmaceutical Co., Ltd., explained in plain language.
-
Experimental injection tested for severe lung failure
Disease control CompletedThis study tested an experimental injection called TISA-818-Inj in patients with Acute Respiratory Distress Syndrome (ARDS), a severe lung condition often requiring breathing machines. Fifty-seven adults with ARDS from pneumonia received either the drug or a placebo for 14 days. …
Phase: PHASE2 • Sponsor: EnliTISA (Shanghai) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First test of new drug in healthy volunteers
Knowledge-focused CompletedThis was the first study in people to check the safety and how the body processes a new drug called TISA-818. It involved 49 healthy adults who received either the drug or a placebo injection. The main goal was to see what side effects might occur and how long the drug stays in t…
Phase: PHASE1 • Sponsor: EnliTISA (Shanghai) Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
First human test: scientists check safety of new drug
Knowledge-focused CompletedThis was the first study in people to check the safety and how the body processes a new drug called UP-818-CC. It involved 73 healthy Chinese volunteers who received either the drug or a placebo. The main goal was to see what side effects occurred and to measure how long the drug…
Phase: PHASE1 • Sponsor: EnliTISA (Shanghai) Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC